Cochrane Abstracts
alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/alemtuzumab_versus_interferon_beta_1a_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed 06 June 2023.
Alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/alemtuzumab_versus_interferon_beta_1a_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed June 6, 2023.
Alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/alemtuzumab_versus_interferon_beta_1a_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_
Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/alemtuzumab_versus_interferon_beta_1a_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis Edited (no change to conclusions)
ID - 432006
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/alemtuzumab_versus_interferon_beta_1a_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
